s6y
Company name or ticker
Search
Neal James R
4
Processa Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Thursday, July 21, 2022
Period
Jul 19, 2022
Accession number
0001567619-22-014305
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header